chrisvoncsefalvay/vaers-outcomes huggingface dataset:
About 4 days after initial vaccine, I experienced R arm and facial paraesthesias. They would last 10 minutes at a time and then resolve. They would continue to happen Intermittently. After the 2nd dose of the Covid vaccine they continued to happen. I went to the ER on 2/11/21 to make sure I wasn?t having a stroke.
Vomiting, Fever >102, diarrhea, arthralgia, myalgia, migraine
I had to go on a Z-PAK after having a cold gave me a secondary infection. I went again to see my granddaughter keeps me getting sick. I do have Immune Deficiency. No I get over the cold but my body fights me in the process. I have a lot of mucus production I do get symptoms when getting vaccine. I get very bad tinnitus and that last a long time, with a headache and lethargic. It took a month for the tinnitus to go away. I had this had this happen with every shot I've had.
Cold; Fever; Headache; soreness/ everything hurts; This case was reported by a consumer via call center representative and described the occurrence of cold in a 68-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of pain in extremity (received 1st dose on an unknown date, refer case US2022AMR026451).   On 10th February 2022, the patient received the 2nd dose of Shingrix (intramuscular) .5 ml. On 11th February 2022, 1 days after receiving Shingrix, the patient experienced cold, fever, headache and pain. On an unknown date, the outcome of the cold, fever, headache and pain were not recovered/not resolved.   It was unknown if the reporter considered the cold, fever, headache and pain to be related to Shingrix.     Linked case(s) involving the same patient:  US2022AMR026451  Additional details were reported as follows: The patient self-reported this case. The patient received a dose of Shingrix and experienced cold, fever, headache and soreness and stated that everything hurts. The symptoms were not resolved. The reporter gave permission to contact healthcare professional. The reporter consented to follow up.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022AMR026451:Same patient, different dose
Pt noticed rash at site of flu vaccine 48 hours after being given. Rash consistent with urtical reaction which then spread to abdomen, arms, legs & face
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 55-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 21Dec2022 as dose 5 (booster), single (Batch/Lot number: unknown) at the age of 55 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: still testing Positive; Positive, notes: Treatment of COVID-19. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical information : The patient received paxlovid for COVID-19 from 08May2023 till 12May2023. Vaccine was received. No other medication in 2 weeks.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.
I received the shingles vaccine and I still got shingles/suspected Vaccination failure; I received the shingles vaccine and I still got shingles; This case was reported by a consumer via media and described the occurrence of suspected vaccination failure in a adult patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but was captured as adult as per vaccine indication. The patient received the shingles vaccine and still got shingles. The reporter stated it was awful and hoped that he or she did not get them  again. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset for target disease and laboratory confirmation were unknown at the time of reporting. No further information would be available.
Received BOOSTRIX at 945 AM. Called agency at 2 pm with headache, nausea, no fever, no vomiting. Felt wiped out, weakness and fatigue, dry mouth.
Patient reported tingling tongue and "maybe" trouble swallowing.  No visible symptoms apparent.  Patient given 25mg oral diphenhydramine solution. Paramedics assessed patient.  Patient recovered well enough to leave under own will.
Rapid heart beat, nausea, light headiness, dry heaves, with five minutes of vaccination. Zyrtec and water given Symptoms subsided with in half an hour
Information has been received from a physician concerning a 15 year old male patient, who on an unknown date was placed on therapy with GARDASIL (dose, route and lot # not reported). It was reported that, on an unknown date, the patient developed symptoms of multiple sclerosis after receiving GARDASIL. At the time of the report, the patient's outcome was unknown. Relatedness for multiple sclerosis symptoms was unknown for GARDASIL. Additional information is not expected.
Day 8 woke up with chills, aches, lethargy,  itching and redness around injection site. Seen by primary MD that day, told to watch it and if gets worse call. Day 9 woke up with chills increased redness and swelling of the top of left arm warm to touch, went to work, reported to employee health, seen by employee health told to call primary . had a telehealth call with primary md recommended antibiotics. later in day redness swelling increased down arm. took 1st dose of keflex 9pm on jan 6th day 9, woke up day 10 feeling better redness and swelling improved will continue to take keflex for the next 7 days.
As of disease investigation date of 8/2/21 case reported onset of symptoms as 7/30/21 which included fever, muscle aches, runny nose, new olfactory disorders, fatigue, cough, wheezing, shortness of breath, abdominal pain and diarrhea.
Arm Soreness, Fatigue,   positional vertigo, nausea, headache.
Moderna vaccine was administered outside of the clinic - reported by patient   OBSTRUCTIVE SLEEP APNEA 9/21/2021 ALCOHOLIC CIRRHOSIS
Mom called and said that the pt was diagnosed with Chickenpox and that she had received the chickenpox shot.
Stroke after first Covid vaccine; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 58-year-old male patient received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown) intramuscular, in arm for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: CEREBROVASCULAR ACCIDENT (medically significant), outcome "recovered", described as "Stroke after first Covid vaccine". The event "stroke after first covid vaccine" required physician office visit.  Clinical course: Caller stated that he had refused to get the Covid booster. No other condition, no investigations performed and no other product used. Caller asked if Pfizer had a compensation program from his Oct shot. Agent does not provide a year. Later in report, Caller corrected some of this information. Patient stated that had six strokes since got the Covid 19 shot. Later in report, Caller corrected this information provided by agent. He had been unable to work for 18 months. The patient can provide the information of hcp later and declined to provide this time. Onset time: first stroke mid-afternoon; second stroke and blood clot mid-afternoon. Patient stated a date but then when clarified later on stated as unknown, he does not have his vaccine card with him at the time of call to provide dates. He went to see his doctor; was not hospitalized, told to stop work. Route of administration reported as left arm maybe. No other prior vaccinations within 4 weeks and no details provided on family medical history relevant to adverse events.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300039677 same product, patient, different AEs, different dose;
NIECE CALLED TO LET US KNOW PATIENT EXPIRED 3 DAYS POST VACCINE SHOT. NIECE STATED PATIENT HAD BREATHING ISSUES AND NOTES MENTION HEART ISSUES.
Developed intermittent fibromyalgia flare-ups and neuropathy pain in both feet and legs. After 2nd vaccine, the flare-ups and neuropathy pain in my feet have become unbearable. This has been ongoing. The nortriptyline had been helping my pain until I received the vaccines. Since the vaccines the pain has reverted back to how it was when I was first diagnosed.
PT did not tell admin that they had received a complete series prior to arrival.  They claimed that it was their first dose.  It was recognized later that they had a complete of Pfizer already done, and had now received a 3rd.
Patient was observed for 15 minutes after injection without adverse reactions. Patient felt dizzy and passed out after leaving the clinic when getting into their vehicle.
Cold like symptoms, severe eye pain, behind eye socket, pain on right side, top of head as if someone was pulling my hair. Right eyelid started to droop.
shingles on the underside of her RIGHT arm; aches and pain; Flu-like symptoms; tiredness; rash/ developed after she took a hot shower; blisters developed after she took a hot shower; This case was reported by a consumer via call center representative and described the occurrence of shingles in a 51-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 11th May 2021, the patient received the 1st dose of Shingrix (intramuscular). On 12th May 2021, 1 days after receiving Shingrix, the patient experienced pain, influenza-like symptoms and tiredness. In May 2021, the patient experienced rash and blister. On 25th May 2021, the patient experienced shingles. The patient was treated with valaciclovir hydrochloride (Valacyclovir). On 14th May 2021, the outcome of the pain, influenza-like symptoms and tiredness were recovered/resolved. On an unknown date, the outcome of the shingles was not recovered/not resolved and the outcome of the rash and blister were unknown.   It was unknown if the reporter considered the shingles, rash and blister to be related to Shingrix. The reporter considered the pain, influenza-like symptoms and tiredness to be related to Shingrix.  Additional details were provided as follows: The patient reported case for herself. The patient received Shingrix vaccine in her right arm. The patient 1 day after receiving the Shingrix vaccine began to have flu-like symptoms, aches and pains and tiredness which all resolved in 2 days. A day before reporting on 25th May 2021, the patient developed shingles on the underside of her right arm. The patient reported that in less than 2 weeks, the rash and blisters developed after she took a hot shower. The patient's health care professional started her on Valacyclovir 1gm trice a day for 7 days, which she started taking on the dat of reporting, 26th May 2021. The reporter did not consent to follow up. The patient did not give permission to contact health care professional.
Verified pt with spouse in room. Went over side effects to look out for, and counseling point. Confirmed with patient what vaccine he was getting (RSV and Flu HD). While discussing about how pt is doing, administered both spouse and pt RSV in Right Deltoid. After administration Realized Two doses was given to patient. Reported to pt will report this to VAERS, what side effects to look out for, to stay at pharmacy for 30 minutes in case of acute reaction. In addition, due to this event and lack of data in being given 1ml of RSV, did not administer Flu HD. Shared if want get Flu HD, would recommend getting vaccine after 2 weeks. Pt and spouse took incident well and stated will report side effects or concerns.
Herpes zoster infection in 2 dermatomes on her back - Right side and left side after injection (2 weeks after).
nerve pain up and down her arm; This case was reported by a other health professional via sales rep and described the occurrence of nerve pain in a female patient who received Flu Seasonal QIV Quebec (FluLaval Quadrivalent) for prophylaxis.   On an unknown date, the patient received FluLaval Quadrivalent at an unknown dose. On an unknown date, unknown after receiving FluLaval Quadrivalent, the patient experienced nerve pain. The patient was treated with ibuprofen (Motrin). On an unknown date, the outcome of the nerve pain was recovered/resolved.   It was unknown if the reporter considered the nerve pain to be related to FluLaval Quadrivalent.  Additional details were provided as follows: The age at vaccination was not reported. The reporter stated that the patient had nerve pain up and down her arm for 2 days following administration.
This case was reported by a physician via call center representative and described the occurrence of fever in an unspecified number of adult patients who received SHINGRIX for prophylaxis. On an unknown date, the patient received SHINGRIX. On an unknown date, unknown after receiving SHINGRIX, the patient experienced fever, myalgia and inflammatory reaction. On an unknown date, the outcome of the fever, myalgia and inflammatory reaction were unknown. It was unknown if the reporter considered the fever, myalgia and inflammatory reaction to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but it was selected as adult as per the vaccine indication. The physician reported that the patients have experienced fever and myalgia when using SHINGRIX. The reporter asked was it recommended that the patients be revaccinated with SHINGRIX 5 to 10 years after the initial series. The reporter asked did the patients that develop a more robust inflammatory response with SHINGRIX (fever, myalgia) tend to develop the most effective immune protection.
Patient was seen in the ED on 5/10/21 after passing out at home resulting in a head laceration. Patient has continued to have issues and has now had 5 episodes of passing out and has been diagnosed with Vertigo.  Patient states she had no prior issues with vertigo prior to vaccination.  She is being see by NP who is completing a full workup including Cardiology.
Client vaccinated in left deltoid  and experienced immediate pain shooting up to the shoulder and neck/head region. Patient applied ice pack to the left deltoid and felt better.
Pt came in to our office on 8/18/21 after dealing with involuntary muscle twitching all over since 8/16/21 that was worsening
REPORTS SHE BROKE OUT IN HIVES ALL OVER HER BODY. WOKE UP THE FOLLOWING DAY W/WELTS/HIVES.  DENIES SOB OR DIFFICULTY BREATHING.    INDICATES SHE WENT TO CLINIC. SAW DR.  WHERE SHE CLAIMS RECIEVED RX. (STERIOD MEDICATION (2 TABS X3DS THEN 1 TAB X 2DS.)
This spontaneous report was received from a Licensed Pratical Nurse, referring to an unspecified number of patients of unknown age and gender. The pertinent medical history and concurrent conditions and the patients was not reported. On unspecified dates, the unspecified number of patients were vaccinated with an unspecified number of improperly stored doses of MMR II lot # K002816, expiration date 25-FEB-2016 (dose, frequency and route were not reported). No adverse experiences were reported. No product quality complaint was involved. This is one of several cases received from the same reporter. Additional information has been requested.
Caller just got out of the hospital after having Covid along with her husband and they both got their 1st dose.; Caller just got out of the hospital after having Covid along with her husband and they both got their 1st dose.; This is a spontaneous report from a contactable consumer received from a Pfizer sponsored program . This consumer reported same events for two patients (for herself and for her husband). This is the second of two reports.  A male patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiration date were not provided), via an unspecified route of administration on an unspecified date at a SINGLE DOSE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. It was reported that the patient just got out of the hospital after having COVID along with her husband and on an unspecified date and they both got their first dose of the vaccine. She wanted to know if they have to get their second dose. The outcome of the events was unknown.  Information on the lot/batch number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021412064 same reporter, drug, and event, different patient
SIDE EFFECTS; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A) dose, start therapy date were not reported for prophylactic vaccination.  No concomitant medications were reported. On an unspecified date, the subject experienced side effects. The outcome of side effects was not reported. This report was non-serious. This case, from the Others is linked to 20210448323.
Covid Vaxx #2  1/20 0815 - shot 12:15 - sore arm 1600 - mild aches and fatigue 1800 - 2cm nodule and redness at injection site 2015 - moderate aches and fatigue, feel like fever is coming 98.2 2130 - severe aches and fatigue, feels like flu 99.2 fever and chills 2300 - can?t sleep, extremely uncomfortable 100.5  1/21 0030 - hot, more uncomfortable and exhausted, need sleep 101.0 took 600mg Advil 0500 - slept ~4 hours, woke up uncomfortable again, temp 99.5 with chills 0730 - woke up hot and uncomfortable, temp 100.0 0930 - woke up hot and uncomfortable, headache and chest tightness, severe back pain, temp 100.5, took Tylenol and ate sandwich 1130 - woke up, hungry, still uncomfortable but okay, temp 98.5 1355 - sudden severe chest pain 1455 - showered and laid down, chest pain subsided, took nap temp 98.5 1610 - woke up hot achy and uncomfortable, temp 101.0 1630 - took Tylenol 2145 - sudden severe chest pain, went to bed, no fever 2330 - chest pain subsided, haven?t slept yet  1/22 0200 - slept for an hour or two, woke up slightly warm, temp 99.7 0500 - woke up sweating, feeling slightly better, temp 98.7 0900 - No more fevers after this point, injection site swollen and raised ~5 cm circle, red and hot to touch, itchy Benadryl helps  1/23 99% better, only symptoms left are injection site soreness and itchiness, and intermittent right sided neck pain relieved with ibuprofen
Patient was updating vaccines since moving to the country. After vaccines were administered, she felt dizzy, clammy, cold and tired. Her BP was checked and was 68/40 at that time. Water offered and watched patient and rechecked BP after about 10 minutes and was 92/58. After another 10 minutes BP was 107/71. Patient was pale in color and clammy and cold, but all symptoms resolved within about 20-30 minutes after vaccines. Patient stated after that this BP drop has happened with each covid vaccine, but she didn't report prior to administration. Oxygen and Heart rate were stable throughout. Patient didn't faint.
On 10/08/2022, while my wife was driving us to the farmer's market, she described that I was speaking gibberish. She couldn't understand what I was saying. By the time we arrived at the market, I was able to explain that something was wrong, and I then went into a seizure. 911 was called and then paramedics arrived immediately, and I was transported to the hospital. They did scans to determine the cause of the seizure and it was ruled as a brain bleed. They reversed the effects of my Warfarin, as they were doing that, I had a second seizure and they managed to avert a third seizure. I am now on an anti-seizure medication. I was in the hospital for 5 days and after being released, I have been regaining my strength every day. There was no permanent damage.
(1 of 2) Tingling/numbing/weakness/discomfort throughout left arm and hand for extended period of time.  I initially thought it was a carpal tunnel injury that occurred during my move, but then realized that it was most likely a vaccine injection related side effect.  The tingling/numbing sensation comes and goes.  It was at its worst about midway between my two Moderna shots.   I had the second shot on my right arm on 5/14/21, and have recently started experiencing some tingling/numbness in my right hand as well.  (2 of 2) My period came early after the first vaccine shot on 4/16/21.  It did not feel like a typical period.  Based on my online research, I think it is possible that the vaccine caused "the womb lining to shed, and lead to spotting or earlier periods."  After the second vaccine dose/shot on 5/14/21, my period is quite late (currently, by about a week).
The above patient was given vaccines on 8/28/08. After receiving the vaccine the patient began feeling warm and dizziness. The patient was carried to examine room. Patient was noted to be drowsy but responsive. No resuscitation given. Patient awake alert, communicative <5 minutes after returning to area.
Patient received Moderna covid-19 vaccine in her left upper arm IM. She started experiencing nausea/throat tightness about 5 minutes after the vaccine was administered. Patient was continually monitored. Throat tightness continued to progress. A capsule of diphenhydramine 25 mg was administered approximately 3 minutes after initial complaints. Patient reported the capsule felt like it "got stuck in her throat" because the throat tightness was continuing to progress. At this time, another pharmacist was on the phone with 911 working on getting an ambulance to the pharmacy. I continued to stay with the patient as breathing got progressively worse, she began wheezing and had very labored breathing. An epipen was obtained from the pharmacy and I administered in the left upper thigh. Shortly after administration, the patient reported starting to feel slightly better and being able to breathe more easily. About 5 minutes after administering the epipen, the ambulance arrived. I briefed the medics on what occurred and what was given to the patient. The patient reported breathing better but still had nausea, felt dizzy, and did not feel well all around. The patient was transported to a local hospital  for treatment.
Patient cried for a prolonged peroid of time, and cried hard, after his injections. Dad was unable to console him. Dad reported the next day that Patient began to wheeze about an hour after his injections and he took him to the Hospital E.R. and Patient received a breathing treatment and was started on steroids. Dad reported no further problems and I am unable to reach him today by phone. Dad stated on June 27, 2018 when he called in the E.R. information that Patient was not having any further difficulties.
P/receiving a dose of Td, pt exp a local rxn @ the site of inject;